RegaDB AREVIR Meeting, Bonn 10-11 April 2008 Pieter Libin Agenda - - PowerPoint PPT Presentation

regadb
SMART_READER_LITE
LIVE PREVIEW

RegaDB AREVIR Meeting, Bonn 10-11 April 2008 Pieter Libin Agenda - - PowerPoint PPT Presentation

RegaDB AREVIR Meeting, Bonn 10-11 April 2008 Pieter Libin Agenda RegaDB software ViroLab data integration ViroLab EUResist collaboration Introduction RegaDB HIV Data and Analysis Management environment To be used by


slide-1
SLIDE 1

RegaDB

AREVIR Meeting, Bonn 10-11 April 2008 Pieter Libin

slide-2
SLIDE 2

Agenda

RegaDB software ViroLab data integration ViroLab – EUResist collaboration

slide-3
SLIDE 3

Introduction

RegaDB

− HIV Data and Analysis Management environment − To be used by

Clinicians Researchers

Two main usage scenarios:

− Runs locally

On a server in your institute On your laptop

− On a collaboration web site − Easy access with Web browser

slide-4
SLIDE 4

Objective

A free and open-source database system Facilitate research collaborations

− Easily interchange data, keeping track of data origin − Create collaborative databases keeping track of dataset versions − Easily publish data sets to Stanford HIVDB

Empower clinicians with analysis tools

− Patient history graph − Sequence analyses

HIV typing and subtyping Genotypic analyses for resistance interpretation Third party analyses as “web services”

− Resistance reports

slide-5
SLIDE 5

Data Entities

Patient Therapy Dataset Test Viral Isolate Attribute

slide-6
SLIDE 6

Attributes

Annotate Patient with information

− Adapts to “your (research) interest” − Typically clinical and epidemiological information

Examples

− Gender − HIV transmission risk group − Most of information collected in SPREAD

Attributes may be grouped (like “SPREAD”)‏

slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

Viral Isolates

Viral Isolates Insertion Nucleotide Sequence Amino Acid Sequence Mutation Protein Information automatically inferred

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14

Treatment

Consists of a drug combination

− commercial or generic representation − dosage information

Start & end date

− support for therapy ending motivation

Commercial drug representation can be

automatically mapped to the generic representation, facilitating use of this data during research

slide-15
SLIDE 15
slide-16
SLIDE 16

Tests

Test (in a general sense) performed at a

certain moment in time

May be related to a

− Viral Isolate − Drug − Combination of a viral isolate and a drug

Adapts to “your (research) interest”

slide-17
SLIDE 17

Tests vs Test Types

Test Type Concept Test Concrete Test Concrete Test Concrete Test Concrete

slide-18
SLIDE 18

Tests vs Test Types

Viral Load Viral Load Generic Viral Load Abbot Viral Load “In house” Viral Load Roche

slide-19
SLIDE 19

Test examples

Tests on a sample:

− CD4 count − Viral Load count

Tests on a sample with respect to a drug

− Therapeutic drug monitoring

Tests on a viral isolate

− HIV typing and subtyping

Tests on a viral isolate with respect to a drug

− Genotypic/phenotypic resistance test

slide-20
SLIDE 20

Research datasets

Patient can be tagged by 1/more datasets User can have access to 1/more datasets Fine grained access to a Patient can be established User access towards a dataset can be

− anonymous-read-only (researchers)‏ − read-only − full read/write (clinicians)‏

slide-21
SLIDE 21

Analysis Services

Built-in services

− REGA Subtype tool − Stanford ASI genotypic resistance algorithms

ANRS, HIVDB, REGA

− Resistance report generation

Using your own template documents

− Patient history visualisation

Integrate with external analysis services

− Using “web services”

slide-22
SLIDE 22
slide-23
SLIDE 23

Collaborative Edition

RegaDB Collaborative Edition Local RegaDB Local RegaDB Local RegaDB Local RegaDB

slide-24
SLIDE 24

Collaborative Version

Easy and secure collaboration The sharing partner stays in control of his

data

− Access can be assigned in a very fine-grained

way

− Privileges can be removed when necessary

Same user environment as the local version

  • f RegaDB
slide-25
SLIDE 25

Research oriented features

Reproducibility

− A single version of a dataset is “immutable”

You can always rerun your analyses by going back to

the original patient group

Research tools

− Query tool to create queries

e.g. “Get one sequence per patient of patients failing

a specific treatment”

possibility to parametrize queries and store them in

RegaDB

dataset security on query level

− Export data to statistical / data mining packages

slide-26
SLIDE 26

Synchronize auxiliary data

Auto-update services for

− Drug definitions − New (versions of) resistance algorithms − Test types / Tests − Attribute types / Attribute groups

slide-27
SLIDE 27

RegaDB technologies

RegaDB is built on the foundations of

− Witty; a AJAX enabled Web Toolkit − Hibernate; a versatile DB layer

Currently we're extending RegaDB towards

  • ther viruses

− HCV, HBV, influenza, ...

slide-28
SLIDE 28

RegaDB usage scenarios

Data management at a local institute Collaboration based on the “Collaborative

Edition”

Data integration

− providing a local institute with clinical/research tools − providing data as a unified schema

slide-29
SLIDE 29

ViroLab data integration

RegaDB is used to integrate ViroLab datasources

− locally installed at the institute − data conversion, extraction, and anonymization is done

within each hospital

slide-30
SLIDE 30

ViroLab data integration

slide-31
SLIDE 31

EUResist – ViroLab

HL7

− standard developed by IBM to communicate

clinical data

− a connector is under developement to convert

from RegaDB <-> HL7

Solution will ensure data origin of the

different partners

slide-32
SLIDE 32

Thanks

Thanks for the invitation and your attention! Questions?